Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02766166 · ClinicalTrials.gov registry record

Critical Health Assessment and Outcomes Score/Study

A clinical trial of Critical Illness and Death, Sudden, sponsored by Johns Hopkins University.

Recruiting
Registry status
200,000
Enrollment target
3
Study locations

NCT02766166: Recruiting study of Critical Illness and Death, Sudden, sponsored by Johns Hopkins University.

NCT02766166 is a study of Critical Illness and Death, Sudden that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 200,000 participants, above the 941-participant average among 91 other Critical Illness trials with a reported enrollment target (21154% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02766166, a study of Critical Illness and Death, Sudden, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
200,000 participants
Enrollment target
3
Study locations

Study Summary

CHAOS is based on the investigator's new and exciting results from pre-clinical and large longitudinal multi-center observational clinical studies of critically ill patients and asymptomatic community-based adults with little or no advanced disease. By integrating approaches from the physical, biological, computational, statistical and clinical sciences, this observational study will test the hypothesis that early diagnosis of subclinical signatures of critical illness encoded within physiological signals complements conventional clinical predictors by providing unique prognostic insight. The primary goal is to reduce mortality, morbidity and complications by early identification of individuals with brewing subclinical critical illness and adverse events before overt clinical presentation (e.g., cardiac arrest, arrhythmias, hemorrhage, respiratory failure, circulatory collapse). This will provide the necessary lead time for healthcare providers to deliver early, more effective and/or preventive therapies. Through innovative approaches, CHAOS also meets the challenge of medical errors to reduce missed diagnosis, misdiagnosis, preventable harm and variability in provider adherence to best practice guidelines. The goal is to validate predictive algorithms and identify subclinical signatures of illness, ranging from asymptomatic adults in the community to very sick patients in the hospital. The overall goal is to make healthcare more precise, effective, efficient, safe and timely while reducing costs, preventable harms and adverse events.

Study Locations (3)

Indiana

  • Indiana University - Indianapolis

Maryland

  • Johns Hopkins University - Baltimore

Ohio

  • University of Cincinnati - Cincinnati

Trial Details

FieldValue
Enrollment Target 200,000 participants
Start Date 2019-09-01
Est. Completion 2027-09-01
Johns Hopkins University

1,448 total trials

What NCT02766166 shows while recruiting

NCT02766166 is an observational study that tracks outcomes without assigning an intervention. Its 200,000 participants enrollment target places it among the larger protocols in the corpus, above the 941-participant average among 91 other Critical Illness trials with a reported enrollment target (21154% higher).

The record links to 2 conditions, with Critical Illness appearing as the primary indexed condition, and to 0 interventions.

NCT02766166 reports a single indexed study location in Indiana, Maryland, Ohio.

Frequently Asked Questions

What is clinical trial NCT02766166 about?

NCT02766166 is a clinical study titled "Critical Health Assessment and Outcomes Score/Study". CHAOS is based on the investigator's new and exciting results from pre-clinical and large longitudinal multi-center observational clinical studies of critically ill patients and asymptomatic community-based adults with little or no advanced disease. By integrating approaches from the physical, biol...

What is the current status of trial NCT02766166?

This trial is currently recruiting. The enrollment target is 200,000 participants. The study started on 2019-09-01. Estimated completion is 2027-09-01.

What conditions does trial NCT02766166 study?

This clinical trial studies the following conditions: Critical Illness, Death, Sudden.

Who is sponsoring clinical trial NCT02766166?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02766166 being conducted?

This trial has 3 study locations across Indiana, Maryland, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Critical Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02766166's enrollment target sits among peer trials

200,000 1st of 91 higher than 91 of 91 other Critical Illness trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Critical Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06090578 · 180,000 participants · NA

    TabCAT Brain Health Assessment in Primary Care

  • NCT06917339 · 156,000 participants

    Retrospective Analyses of TrakStar Database

  • NCT06232551 · 152,000 participants · NA

    Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism

  • NCT04735835 · 250,000 participants · NA

    Personalized Responses to Dietary Composition Trial 3

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02766166, the US trial registry maintained by the National Library of Medicine. NCT02766166 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.